|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes |
IUPAC Name ![]() |
| ethyl({1-[3-(trifluoromethyl)phenyl]propan-2-yl})amine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5818 | dexfenfluramine |
| 1596 | fenfluramine |
Synonyms ![]() |
| Adifax® |
| Pondimin® |
Database Links ![]() |
|
| CAS Registry No. | 458-24-2 (source: Scifinder) |
| ChEBI | CHEBI:5000 |
| ChEMBL Ligand | CHEMBL87493 |
| DrugBank Ligand | DB01191 |
| PubChem CID | 3337 |
| Search Google for chemical match using the InChIKey | DBGIVFWFUFKIQN-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | DBGIVFWFUFKIQN |
| Search PubMed clinical trials | fenfluramine |
| Search PubMed titles | fenfluramine |
| Search PubMed titles/abstracts | fenfluramine |
| Wikipedia | Fenfluramine |
| Comments |
| The approved drug was called dexfenfluramine, but was withdrawn from use due to adverse cardiac events [1,3]. |